Astex Pharmaceuticals To Participate On Epigenetics Panel At Rodman & Renshaw Conference

DUBLIN, Calif., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.J. Manuso, PhD, chairman and chief executive officer, will participate in a Rodman & Renshaw Global Investment Conference panel discussion titled, "Epigenetics: The Silent Revolution in Oncology Research" on Monday, September 10th at 9:15 a.m. ET in New York.

Key opinion leader Jean-Pierre Issa, MD, director, Fels Institute for Cancer Research and Molecular Biology, Temple University will also be speaking on the panel, amongst others.

About Astex Pharmaceuticals

Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed DacogenĀ® (decitabine) for Injection and receives significant royalties on global sales.

For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com .

The Astex Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=12273
CONTACT: Timothy L. Enns         Astex Pharmaceuticals, Inc.         Senior Vice President         Corporate Communications & Marketing         Tel:  +1 (925) 560-2810         E-mail:  tim.enns@astx.com                  Susanna Chau         Astex Pharmaceuticals, Inc.         Manager         Investor Relations         Tel:  +1 (925) 560-2845         E-mail:  susanna.chau@astx.com                  Alan Roemer         The Trout Group         Managing Director         Tel:  +1 (646) 378-2945         E-mail: aroemer@troutgroup.com                  Kari Watson         MacDougall Biomedical Communications         Senior Vice President         Tel: +1 (781) 235-3060         E-mail: kwatson@macbiocom.com

Astex Pharmaceuticals, Inc. logo

If you liked this article you might like

Trade-Ideas: Astex Pharmaceuticals (ASTX) Is Today's Pre-Market Mover With Heavy Volume Stock

Biotech Stock Mailbag: Astex Pharma, My Essential Twitter Follows

Trade-Ideas: Astex Pharmaceuticals (ASTX) Is Today's "Perilous Reversal" Stock

4 Biotech Stocks Under $10 to Trade for Breakouts

Astex Pharmaceuticals Inc Stock Downgraded (ASTX)